Tender for Haffkine Bio-pharmaceuticals Corporation Limited - NTID 23431386
Haffkine Bio-pharmaceuticals Corporation Limited
Mumbai, Maharashtra, India
NTID 23431386
- Opening Date : Fri 30th April, 2021
- Closing Date : Thu 29th April, 2021
- ₹ 0.00
- NTID 23431386
corrigendum : supply of injections phase i (2020-21) - adrenaline 1 mg/ml inj, amikacin sulphate 500 mg inj, amikacine sulphate250 mg - 2 ml inj., amikacin sulphate 100 mg inj, aminophylline inj 25mg/ml, amoxycillin + calvulanic acid 1.2 gm (amoxycillin sodium 1000 mg + clavulanic acid as potassium salt 200 mg i.e. 1.2 gm in vial, amoxycillin + calvulanic acid 300 mg inj. (amoxycillin sodium 250mg + clavulanic acid 50 mg per vial inj), amoxycillin sodium 500mg + clavulanic acid 100mg per vial inj, ampicillin 500 mg inj, anti-d immunoglobulin inj mono/polyclonal 300 mcg, artesunate 60 mg vial inj., atracurium besylate 10mg/ml inj, atropine sulphate 0.6 mg/ml inj, betamethasone 4mg/ml inj, benzathine penicillin g 12,00,000 i.u./vial inj, bupivacaine hydrochloride (heavy) 5 mg + dextrose monohydrate 80 mg/ml inj, bupivacaine heavy mixed with glucose solution inj. 4 ml, calcium gluconate 10 % w/v inj, cefoperazone and sulbactum 2gm inj, cefoperazone and sulbactum 1 gm inj, cefotaxime 1000 mg inj, cefatoxime 500 mg inj., ceftazidime 1000 mg inj, ceftazidime inj 500 mg, ceftriaxone 1000 mg inj, ceftrixone 500 mg inj., cefuroxime 750 mg inj, daltiparin 2500 iu (low molecular weight heparin 2500 iu), dalteparine sodium5000 iu anti factor inj, desflurane, dexamethasone sodium phosphate 4 mg/ml inj., diazepam 5 mg/ml inj, diclofenac 25 mg/ml inj, diclofenac sodium 75 mg/ml inj iv bolus injection 1 ml amp, dicyclomine hydrochloride inj. 10mg/ml, dobutamine inj. 50mg/ml, dopamine hci. 40 mg/ml (i.e.200 mg/ 5 ml) inj, dulaglutide 1.5mg/vial inj., enoxaparin sodium 40mg inj, enoxaparin sodium 60mg inj, erythropoitin 4000 i.u. inj, erythropoetin recombinant inj 2000 iu, erythropoitin 10000 i.u. inj, ethamsylate inj. 125mg/ml, 2ml amp, etophylline 169.4 mg + theophyllin 50.6 mg inj, frusemide 10mg/ml inj, gentamycin sulphate 40mg inj, haloperidol deconoate depot inj. 50 mg/ml, heparin sodium 1000 i.u./ml inj, heparin sodium 5000 i.u./ml inj, hepatitis b immunoglobulin 100 i. u., hepatitis b immunoglobulin 200 i. u., human insulin plain 40iu/ml, human- albumin 20% inj, insulin lispro mix 25/75 pen with needle pack size - 1 pen with needle, hyluronidase inj. 2ml, hydroxy propyl methyl cellulose usp 2% in sterile isonic base pfs inj, human normal immunoglobulin for intravenous use 5gm, human tetanus immunoglobulin 250 i.u. inj, antitetanus human immunoglobin inj, antitetanus human immunoglobin inj, hydrocortisone sodium succinate 100 mg/vial inj, hydroxyethyl starch (hetastarch) inj 6% 500ml, imipenem 500 mg + cillastatin 500 mg per vial inj, infliximab 100 mg inj., iron sucrose 20mg/ ml inj, isoflurane (usp/ip/bp), ketamine hydrochloride 50mg/ml inj, lignocaine or lidocaine or xylocaine hcl 0.01(1%) 30 ml inj, lignocaine or lidocaine or xylocaine hcl 0.02(1%) 30 ml inj, lignocaine hydrochloride ip with dextrose hyperbaric (heavy) inj, lignocaine or lidocaine or xylocaine hcl 20mg, adrenaline or epinephrine 5mcg, per ml) 30ml inj, inj. lorazepam 2mg, inj magnesium sulphate 50% w/v, mephentermine sulphate 35mg /ml-10 ml inj, meropenam 1 gm inj, meropenam 500 mg inj, methyl ergometrine maleate 0.2 mg/ml inj, methyl prednisolone acetate 40mg/ml - 1 ml or 2 ml inj, methyl prednisolone inj 125mg/2ml, methyl prednisolone sodium succinate 500 mg/vial inj, methyl prednisolone sodium succinate 1 gm/vial inj, metoclopramide hydrochloride 5 mg/ml inj, midazolam 1mg /ml inj, neostigmine methyl sulphate 0.5 mg/ml inj, nitroglycerine 5 mg/ml inj, noradrenaline 2 mg / ml inj, ondansetron inj ip 2 mg/ml inj, oxytocin 5 i.u./ml inj, inj. paliperidone palmitate 75mg, inj. paliperidone palmitate 100mg, pantaprazole 40 mg/ 10 ml inj, paracetamol 150 mg/ml inj, paracetamol 10 mg/ml inj, pentazocine lactate 30 mg/ml inj, phenytoin sodium 50 mg/ml - 2 ml (diphenyl hadantoin sodium ) inj., piperacilin 4gm + tazobactum 0.5 g inj, pralidoxime chloride 500 mg (pam) inj., pralidoxime chloride 1 gm (pam) inj., promethazine inj 50mg/ml, propofol 1% mct/lct in fat emulsion with oleic acid i.e. 10 mg/ml - 20 ml vial inj, inj propofol 2% mct/lct in fat emulsion with oleic acid i.e. 10 mg/ml - 10 ml vial/amp, prostaglandin (carboprost) inj. 250mcg/ml, rabies immunoglobin - anti rabies serum, rabies immunoglobulin 300 iu/ml inj, rabies vaccines, human (cell culture) potency of not less than 2.5 units per vial. i.p. for id use (tissue culture anti rabies, rabies vaccines, human (cell culture) potency of not less than 2.5 units per vial. i.p. for im use (tissue culture anti rabies, risperidone 25mg inj., rocuronium 50 mg/ 5 ml inj, sevoflourane, sevoflourane 100 ml, sodium bicarbonate inj., sodium nitropruside 50 mg inj, sterile water for injection, sterile water for injection, streptokinase 7.5 lac i.u.inj, streptokinase 15 lac i.u. inj, inj. tenecteplase 20 mg, inj. tenecteplase 40mg, tetanus toxoid (adsorbed), tramadol 50 mg /ml inj, tranxamic acid 500 mg/ 5 ml, urokinase inj. 10 lac iu, vancomycin 500 mg inj, vancomycin 1 gm inj., vecuronium bromide 4 mg inj, vitamin k3 water soluble inj, premix insulin 30:70 injection recombinant human insulin biphasic 30%, regular 70% 100 iu/ml, inj. lung surfactant 5ml, surfactant for intratrecheal instillation (natural bovine lung surfactant) minimum labelled shelf life (in months 18 ), surfactant for intratrecheal instillation (natural bovine lung surfactant) minimum labelled shelf life (in months 18 ), non ionic 370 iopromide / ioversol / iohexol / iopamidol 370 mg/ml/ iobitridol 350 mg indian fda/dcgi approved with who, non ionic 370 iopromide / ioversol / iohexol / iopamidol 370 mg/ml/ iobitridol 350 mg india fda/dcgi approved with who, non- ionic 300 iopromide/ioversol/ iohexol / iopamidol 300 mg/mlindia fda/dcgi approved with who gmp certificate or, mri contrast media inj. gadolinium / gadoversetamide / gadodiamide / gadopentetate 0.5 molar 0.5 mmol / ml/gadoteric
Documents
Unlock the opportunities
Buy This Document-
721.3 kBOil_India_ExtraDoc...Oil_India_ExtraDocument-GCO0449P23.pdf
-
721.3 kBOil_India_ExtraDoc...Oil_India_ExtraDocument-GCO0449P23.pdf
Costs
-
EMD
8694000.00 -
Document Cost
792000.00 -
Estimated Cost
Refer Documents
Purchase Access To Download Selected Documents
₹ 200
Select this PlanFor a one-time fee, you get unrestricted access to all documents and for a minimum of one year.
UNLIMITED
DOWNLOAD
Select this Plan
₹ 7000
Plan
Standard Plane
Day/Month
Standard Plane